Celcius Launches Rs 500 Million Pharma Logistics Arm
WAREHOUSING & LOGISTICS

Celcius Launches Rs 500 Million Pharma Logistics Arm

Celcius Logistics, India’s leading tech-driven 3PL and cold supply chain provider, has launched Celcius+, a dedicated vertical for the seamless management of the pharmaceutical supply chain. The new arm is designed to meet the sector’s stringent demands for temperature control, compliance, and real-time visibility, ensuring safe and efficient transport of medicines, vaccines, and other sensitive products.
In its first phase, the company will invest Rs 500 million to build a dedicated pharma fleet and supporting infrastructure, aiming to generate Rs 1 billion in annual recurring revenue (ARR) from this vertical within 18 months. Of this, Rs 350 million will be used to deploy 100 new reefer vehicles along key pharmaceutical corridors across India, while Rs 100–150 million is earmarked for developing a robust pharma courier system for high-demand urban and semi-urban markets.
To drive this expansion, Celcius will hire 30–40 specialists in pharma logistics, operations, and compliance. Leveraging its advanced tech platform, Celcius+ will provide real-time tracking, continuous temperature monitoring, and AI-enabled route optimisation, ensuring shipments comply with the highest quality standards.
Founder and CEO Swarup Bose said: “With Celcius+, we are expanding capacity while setting new benchmarks for safety, transparency, and operational excellence in pharma logistics. Our investment marks the start of a focused journey to reduce wastage, ensure compliance, and bridge gaps in pharma distribution with technology-driven solutions.”
Celcius+ plans to partner with leading pharmaceutical companies and extend its reach to over 100 cities by the end of 2025. Its services will cover primary and secondary distribution, as well as last-mile pharma courier delivery for high-value products including vaccines, biologics, insulin, and specialty medicines.
The 24-ft reefer fleet will be equipped with advanced telematics, digital lock systems, CCTV surveillance, and 24/7 tracking via a central control tower. This infrastructure is designed to guarantee product integrity and fast response to any disruptions.
Earlier this year, Celcius Logistics raised Rs 2.5 billion in an oversubscribed Series B round to accelerate technology upgrades and network expansion. Currently operating across 600 cities, the company aims to scale to more than 1,000 cities in the coming years, with Celcius+ strengthening its presence in pharmaceutical logistics.

"Join industry leaders at RAHSTA Expo, India's premier platform for roads, highways and traffic infrastructure. Register now to explore innovations, network with experts and shape the future of mobility."

Celcius Logistics, India’s leading tech-driven 3PL and cold supply chain provider, has launched Celcius+, a dedicated vertical for the seamless management of the pharmaceutical supply chain. The new arm is designed to meet the sector’s stringent demands for temperature control, compliance, and real-time visibility, ensuring safe and efficient transport of medicines, vaccines, and other sensitive products.In its first phase, the company will invest Rs 500 million to build a dedicated pharma fleet and supporting infrastructure, aiming to generate Rs 1 billion in annual recurring revenue (ARR) from this vertical within 18 months. Of this, Rs 350 million will be used to deploy 100 new reefer vehicles along key pharmaceutical corridors across India, while Rs 100–150 million is earmarked for developing a robust pharma courier system for high-demand urban and semi-urban markets.To drive this expansion, Celcius will hire 30–40 specialists in pharma logistics, operations, and compliance. Leveraging its advanced tech platform, Celcius+ will provide real-time tracking, continuous temperature monitoring, and AI-enabled route optimisation, ensuring shipments comply with the highest quality standards.Founder and CEO Swarup Bose said: “With Celcius+, we are expanding capacity while setting new benchmarks for safety, transparency, and operational excellence in pharma logistics. Our investment marks the start of a focused journey to reduce wastage, ensure compliance, and bridge gaps in pharma distribution with technology-driven solutions.”Celcius+ plans to partner with leading pharmaceutical companies and extend its reach to over 100 cities by the end of 2025. Its services will cover primary and secondary distribution, as well as last-mile pharma courier delivery for high-value products including vaccines, biologics, insulin, and specialty medicines.The 24-ft reefer fleet will be equipped with advanced telematics, digital lock systems, CCTV surveillance, and 24/7 tracking via a central control tower. This infrastructure is designed to guarantee product integrity and fast response to any disruptions.Earlier this year, Celcius Logistics raised Rs 2.5 billion in an oversubscribed Series B round to accelerate technology upgrades and network expansion. Currently operating across 600 cities, the company aims to scale to more than 1,000 cities in the coming years, with Celcius+ strengthening its presence in pharmaceutical logistics.

Next Story
Real Estate

Pecan Realty Completes Rs 1.5 Billion Transactions

Pecan Realty has recently completed four institutional transactions worth over Rs 1.5 billion over the past two years, strengthening its position as an execution-led real estate platform. The deals include resolution-led acquisitions, structured finance transactions and capital partnerships across its development portfolio.The transactions covered acquisitions through the National Company Law Tribunal process and helped provide repayment or exits to both private and public sector lenders. The company said the deals demonstrate its ability to resolve complex project situations, work with instit..

Next Story
Real Estate

SNN Estates Expands North Bengaluru Housing Project

SNN Estates has announced an expansion of its SNN Estates Felicity residential project in North Bengaluru following strong buyer demand, with 75 per cent of the first-phase inventory sold within three days of launch.The developer will add 76 apartments in the new phase, taking the project's estimated revenue potential to around Rs 1,000 crore upon completion of Phase 2.Spread across 6.5 acres in Rachenahalli, near Manyata Tech Park, the project comprises 604 apartments in 1.5, 2, 2.5, 3 and 4 BHK configurations. The development includes a 50,000-sq-ft clubhouse with amenities such as sports co..

Next Story
Infrastructure Urban

SCG Drives ASEAN Industrial Transformation Strategy

SCG is strengthening its focus on ASEAN as a key growth region by advancing industrial transformation, enhancing competitiveness and building resilient regional value chains. Thammasak Sethaudom, President and Chief Executive Officer, SCG, highlighted the need for industries to continuously develop capabilities, strengthen resilience and deepen regional cooperation to achieve sustainable long-term growth.SCG views ASEAN as an important growth engine alongside China, supported by favourable demographics, trade connectivity and investment flows. With ASEAN’s GDP projected to grow by around 4.7..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement